The tax exemption has been withdrawn from Matrivani Institute of Experimental Research and Education, Herbicure Health Bio-Herbal Research Foundation and School of Genetics and Population Health.
Matrivani was given the exemption under section 35 of the Income Tax Act in August 2007 while the Herbicure got the exemption in March 2008.
School of Genetics and Population Health had got the exemption in January 2010.
The Income Tax Act provides for tax deductions for promoting research and development activities.
The benefit is also withdrawan if the organisation ceases to carry on its research activities or its research activities are not found to be genuine.
The Central Board of Direct Taxes had withdrawn the notifications granting approval exemption to the entities, a notification said.
The entities were given the exemption under the category of 'other institution' partly engaged in research activities.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
